< Terug naar vorige pagina
Onderzoeker
Heidi Segers
- Disciplines:Morfologische wetenschappen, Oncologie
Affiliaties
- Pediatrische Oncologie (Afdeling)
Lid
Vanaf1 okt 2016 → Heden
Projecten
1 - 3 of 3
- Klonale heterogeniteit en evolutie tijdens chemotherapie in acute lymfatische leukemie bij kinderenVanaf14 sep 2021 → HedenFinanciering: Eigen Middelen zoals patrimonium, inschrijvingsgelden, giften, ....
- Selectieve inhibitie van PSEN1 gamma-secretase als behandeling van acute T-cel lymfatische leukemie (T-ALL)Vanaf25 aug 2020 → HedenFinanciering: Eigen Middelen zoals patrimonium, inschrijvingsgelden, giften, ....
- Klonale evolutie en biologie van samenwerkende oncogene mutaties in acute lymfatische leukemie.Vanaf1 okt 2018 → 30 sep 2023Financiering: Fonds Recuperatie Fiscale Vrijstelling
Publicaties
1 - 10 van 37
- Targeted therapies in children with renal cell carcinoma (RCC): An International Society of Pediatric Oncology-Renal Tumor Study Group (SIOP-RTSG)-related retrospective descriptive study(2024)
Auteurs: Heidi Segers
- Clonal Heterogeneity and Evolution during Treatment in High Hyperdiploid B-Cell Acute Lymphoblastic Leukemia(2023)
Auteurs: Margo Aertgeerts, Jolien De Bie, Heidi Segers
- The Effect of Immunoglobulin Prophylaxis on Infectious Morbidity in Pediatric Patients with Acute Lymphoblastic Leukemia: Results of a Randomized Controlled Trial(2023)
Auteurs: Heidi Segers
- Induced pluripotent stem cell-derived cardiac myocytes to assess anthracycline cardiotoxicity(2023)
Auteurs: Johanna Jacobs, Robin Duelen, Ward Heggermont, Maurilio Sampaolesi, Heidi Segers, Lucas Van Aelst
- Randomized controlled trial on the effect of 1-hour infusion of vincristine versus push injection on neuropathy in children with cancer (final analysis)(2023)
Auteurs: Heidi Segers
Pagina's: 19480 - 19490 - Combination therapy of a PSEN1-selective γ-secretase inhibitor with dexamethasone and an XPO1 inhibitor to target T-cell acute lymphoblastic leukemia(2023)
Auteurs: Charlien Vandersmissen, David Nittner, Johan Maertens, Heidi Segers, Jan Cools
Pagina's: 2507 - 2512 - Induced Pluripotent Stem Cell-derived Cardiac Myocytes To Assess Anthracycline Cardiotoxicity(2023)
Auteurs: Johanna Jacobs, Robin Duelen, Ward Heggermont, Heidi Segers
- Transcription factor NKX2-1 drives serine and glycine synthesis addiction in cancer(2023)
Auteurs: Elien Heylen, Paulien Verstraete, Linde Van Aerschot, Tom Venken, David Nittner, Anne Uyttebroeck, Heidi Segers, Diether Lambrechts, Jan Cools, Kim De Keersmaecker, et al.
Pagina's: 1862 - 1878 - Effect of chemotherapy (with and without radiotherapy) on the intelligence of children and adolescents treated for acute lymphoblastic leukemia; a meta-analysis(2023)
Auteurs: Jurgen Lemiere, Charlotte Sleurs, Heidi Segers, Marina Danckaerts
Pagina's: 492 - 505 - Genetic Polymorphisms Associated with Vincristine Pharmacokinetics and Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology Patients(2022)
Auteurs: Heidi Segers